Capital Analysts LLC’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-17,500
| Closed | -$102K | – | 827 |
|
|
2020
Q3 | $102K | Buy |
17,500
+1,000
| +6% | +$5.83K | 0.01% | 310 |
|
|
2020
Q2 | $111K | Sell |
16,500
-1,000
| -6% | -$6.73K | 0.01% | 269 |
|
|
2020
Q1 | $111K | Buy |
17,500
+922
| +6% | +$5.85K | 0.01% | 248 |
|
|
2019
Q4 | $173K | Buy |
16,578
+6,328
| +62% | +$66K | 0.02% | 245 |
|
|
2019
Q3 | $40K | Buy |
10,250
+1,125
| +12% | +$4.39K | ﹤0.01% | 414 |
|
|
2019
Q2 | $136K | Buy |
9,125
+1,000
| +12% | +$14.9K | 0.01% | 247 |
|
|
2019
Q1 | $201K | Buy |
8,125
+7,375
| +983% | +$182K | 0.02% | 216 |
|
|
2018
Q4 | $13K | Buy |
750
+500
| +200% | +$8.67K | ﹤0.01% | 445 |
|
|
2018
Q3 | $7K | Sell |
250
-900
| -78% | -$25.2K | ﹤0.01% | 468 |
|
|
2018
Q2 | $52K | Buy |
1,150
+575
| +100% | +$26K | 0.01% | 324 |
|
|
2018
Q1 | $30K | Buy |
575
+325
| +130% | +$17K | ﹤0.01% | 360 |
|
|
2017
Q4 | $17K | Sell |
250
-1,100
| -81% | -$74.8K | ﹤0.01% | 372 |
|
|
2017
Q3 | $111K | Buy |
+1,350
| New | +$111K | 0.01% | 231 |
|